Laboratory Tests for Diagnosing Autoimmune Hepatitis
The diagnosis of autoimmune hepatitis requires a comprehensive panel of tests including liver function tests, immunoglobulins (particularly IgG), conventional autoantibodies (ANA, SMA, anti-LKM1, AMA), and supplemental autoantibodies (anti-SLA/LP, anti-actin, anti-LC1, pANCA) when conventional tests are negative. 1, 2
Initial Laboratory Evaluation
Essential Tests:
Liver Function Tests
- Serum AST/ALT (typically elevated)
- Alkaline phosphatase (AP:AST ratio <1.5 supports AIH) 1
- Bilirubin
Immunoglobulins
Conventional Autoantibodies
- Antinuclear antibody (ANA)
- Smooth muscle antibody (SMA)
- Anti-liver/kidney microsome type 1 (anti-LKM1)
- Antimitochondrial antibody (AMA) - to exclude PBC 1
Supplemental Autoantibodies (if conventional tests negative):
- Anti-soluble liver antigen/liver pancreas (anti-SLA/LP)
- Anti-actin (F-actin)
- Anti-liver cytosol type 1 (anti-LC1)
- Perinuclear anti-neutrophil cytoplasmic antibodies (pANCA) 1, 2
Exclusion Testing
Viral Hepatitis Markers
- Hepatitis A, B, and C serologies (must be negative) 2
Metabolic/Genetic Disease Testing
- α1-antitrypsin phenotype
- Serum ceruloplasmin and copper levels (to exclude Wilson disease)
- Iron studies (to exclude hemochromatosis) 2
In patients with multiple endocrine disorders
Interpretation of Results
AIH Classification Based on Autoantibody Profile:
Type 1 AIH (80% of cases)
Type 2 AIH
Diagnostic Scoring Systems:
Original Revised Scoring System (1999)
Simplified Scoring System (2008)
- Definite AIH: ≥7 points
- Probable AIH: ≥6 points 2
Important Considerations
Liver biopsy is essential for definitive diagnosis, showing interface hepatitis with lymphoplasmacytic infiltrates 1, 2
In acute or fulminant AIH, approximately 25-39% of patients may have normal IgG levels 2
Autoantibody testing should be performed by indirect immunofluorescence at an initial dilution of 1/40 in adults and 1/10 in children 3
Anti-LKM-1 can be confused with AMA if rodent kidney is used as the sole immunofluorescence substrate 3
Common Pitfalls to Avoid
Relying solely on conventional autoantibodies; up to 5% of AIH patients may be seronegative for standard markers 2, 4
Overlooking AIH in patients with normal IgG levels, particularly in acute presentations 2
Confusing the pattern of immunoglobulin elevation (IgG vs. IgA vs. IgM) when differentiating between AIH and other liver diseases 2
Failing to test for supplemental autoantibodies when conventional tests are negative but clinical suspicion remains high 1, 2